Thurston, Springer, Miller, Herd & Titak, Inc. Sanofi Transaction History
Thurston, Springer, Miller, Herd & Titak, Inc.
- $558 Million
- Q1 2025
A detailed history of Thurston, Springer, Miller, Herd & Titak, Inc. transactions in Sanofi stock. As of the latest transaction made, Thurston, Springer, Miller, Herd & Titak, Inc. holds 1,884 shares of SNY stock, worth $92,673. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,884
Previous 173
989.02%
Holding current value
$92,673
Previous $8,000
1200.0%
% of portfolio
0.02%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding SNY
# of Institutions
861Shares Held
270MCall Options Held
1.71MPut Options Held
1.76M-
Dodge & Cox San Francisco, CA73.2MShares$3.6 Billion2.48% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.6MShares$667 Million0.33% of portfolio
-
Invesco Ltd. Atlanta, GA11.9MShares$583 Million0.13% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11MShares$543 Million0.08% of portfolio
-
Bank Of America Corp Charlotte, NC10.4MShares$512 Million0.05% of portfolio
About Sanofi
- Ticker SNY
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,508,100,096
- Market Cap $123B
- Description
- Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...